the lancet oncology

lancet oncol ISSN 1474-5488 341 views

Indexed In

scopus ncbi

Publications

9

Details

Abbreviated Name: lancet oncol
ISSN: 1474-5488

Publications/Year

Top Clicked Bibliographies from Search

9

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study

2017 388 clicks

4

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.

2016 278 clicks

1

Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.

2019 275 clicks

2

Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial.

2016 252 clicks

7

Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report.

2020 244 clicks

8

Radiotheranostics: a roadmap for future development.

2020 209 clicks

5

Is India ready to lead the battle for fair access to medicines?

2013 197 clicks

3

Erratum: Correction to Lancet Oncol 2019; 20: 408-19 (The Lancet. Oncology (2019) 20 3 (408-419) PII: S1470-2045(19)30587-X)

2019 182 clicks

6

Pancreatic cancer: a neglected killer?

2010 171 clicks